bispecific trivalent antibodies to claudin6 or claudin18.2 and cd3-binding antibodies for the treatment of carcinomas expressing claudin

摘要

The present disclosure provides binding agents comprising at least three binding domains, wherein a first binding domain binds to a specific cell antigen and a second binding domain and a third claudin binding domain and methods of using them. binding agents or nucleic acids coding for the treatment of cancer.